117 related articles for article (PubMed ID: 2218829)
1. Prognostic indicators in invasive breast cancer.
Sunderland MC; McGuire WL
Surg Clin North Am; 1990 Oct; 70(5):989-1004. PubMed ID: 2218829
[TBL] [Abstract][Full Text] [Related]
2. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators in node-negative early stage breast cancer.
Wong WW; Vijayakumar S; Weichselbaum RR
Am J Med; 1992 May; 92(5):539-48. PubMed ID: 1580300
[TBL] [Abstract][Full Text] [Related]
4. Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis.
Cañizares F; Sola J; Pérez M; Tovar I; De Las Heras M; Salinas J; Peñafiel R; Martínez P
Tumour Biol; 2001; 22(5):273-81. PubMed ID: 11553856
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in breast cancer.
Saez RA; McGuire WL; Clark GM
Semin Surg Oncol; 1989; 5(2):102-10. PubMed ID: 2657970
[TBL] [Abstract][Full Text] [Related]
6. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
7. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
Allred DC; Clark GM; Tandon AK; Molina R; Tormey DC; Osborne CK; Gilchrist KW; Mansour EG; Abeloff M; Eudey L
J Clin Oncol; 1992 Apr; 10(4):599-605. PubMed ID: 1548522
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.
Gasparini G; Meli S; Panizzoni GA; Visonà A; Boracchi P; Bevilacqua P; Marubini E; Pozza F
Breast Cancer Res Treat; 1992 Mar; 20(3):195-204. PubMed ID: 1571572
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189.
Simpson JF; Gray R; Dressler LG; Cobau CD; Falkson CI; Gilchrist KW; Pandya KJ; Page DL; Robert NJ
J Clin Oncol; 2000 May; 18(10):2059-69. PubMed ID: 10811671
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in breast cancer.
Merkel DE; Osborne CK
Hematol Oncol Clin North Am; 1989 Dec; 3(4):641-52. PubMed ID: 2558104
[TBL] [Abstract][Full Text] [Related]
13. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
Winter K; Eidtmann H; Jonat W
Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
[TBL] [Abstract][Full Text] [Related]
15. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptors and other prognostic factors in primary breast cancer.
Clark GM; McGuire WL
Semin Oncol; 1988 Apr; 15(2 Suppl 1):20-5. PubMed ID: 3285482
[TBL] [Abstract][Full Text] [Related]
18. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
19. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
[TBL] [Abstract][Full Text] [Related]
20. [DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].
Pinto AE; Pereira T; Silva GL; Ferreira MC; André S
Acta Med Port; 2012; 25(6):399-407. PubMed ID: 23534591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
